Research entry

GLP-3 (RT)

Acts on three receptors at once

In plain terms

GLP-3 (RT) is a synthetic peptide that acts on the GLP-1, GIP and glucagon receptors together — most peptides in this family act on only one. Published trials have studied compounds in this class for effects on blood sugar regulation and body weight. Sold here strictly as a reference standard for laboratory use.

Research overview

GLP-3 (RT) is a synthetic triple agonist acting on the GLP-1, GIP and glucagon receptors simultaneously. Research interest comes from whether engaging all three does something the single- and dual-receptor compounds do not. It is the newest of the class and the literature is correspondingly thinner.

What has been studied

1
Three receptors at once
GLP-3 (RT) acts on the GLP-1, GIP and glucagon receptors simultaneously. Research interest comes from the idea that engaging all three does something the single-receptor compounds do not.
2
Metabolic models
Animal studies have measured blood glucose handling, food intake and body composition.
3
Compared against the class
Most of the published work sets it against single- and dual-receptor agonists in the same models, which is why researchers commonly order more than one of the class.

Research articles

All research cited here is drawn from peer-reviewed scientific literature and provided for informational and educational purposes only. PureChain products are sold strictly for laboratory and research use — not for human consumption, therapeutic use, or clinical application of any kind. Nothing on this page is medical advice.